These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6088743)

  • 21. Considerations on the sensitization properties of Bordetella pertussis.
    Kirchev P; Vesselinova H; Boshkov B; Galabov S
    Nauchni Tr Vissh Med Inst Sofiia; 1969; 48(1):59-63. PubMed ID: 4191303
    [No Abstract]   [Full Text] [Related]  

  • 22. [The protective action of cell walls and cytoplasm of Bordetella pertussis].
    Milleck J
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Jul; 133(2):126-33. PubMed ID: 4298314
    [No Abstract]   [Full Text] [Related]  

  • 23. Conversion from Bordetella parapertussis to B pertussis.
    Rappuoli R; Gross R; Aricò B
    Lancet; 1987 Aug; 2(8557):511. PubMed ID: 2887801
    [No Abstract]   [Full Text] [Related]  

  • 24. Adjuvants for a tumor-specific vaccine: Bordetella pertussis or mycobacterial cell walls attached to oil droplets.
    Bartlett GL; Zbar B
    J Natl Cancer Inst; 1973 May; 50(5):1385-90. PubMed ID: 4351399
    [No Abstract]   [Full Text] [Related]  

  • 25. Variation in Bordetella pertussis.
    Cameron J
    J Pathol Bacteriol; 1967 Oct; 94(2):367-74. PubMed ID: 4294462
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cell components of Bordetella pertussis and their biological activities].
    Sato Y; Arai H
    Tanpakushitsu Kakusan Koso; 1972; 17(2):139-49. PubMed ID: 4337077
    [No Abstract]   [Full Text] [Related]  

  • 27. Disruption of Bordetella pertussis in the Ribi cell fractionator. 1. Effect of different pressures.
    Hollinger E; Wardlaw AC
    Can J Microbiol; 1971 Sep; 17(9):1169-74. PubMed ID: 4329814
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bordetella pertussis spheroplasts. 2. The protective action of spheroplasts and spheroplast fractions].
    Milleck J; Ocklitz HW
    Zentralbl Bakteriol Orig A; 1972 Jan; 219(1):85-92. PubMed ID: 4402416
    [No Abstract]   [Full Text] [Related]  

  • 29. Disturbance of mice tracheal beta-adrenoceptor and cholinergic receptor function by Bordetella pertussis and its cell wall components.
    Veenendaal GH; Kool DJ; de Wildt DJ; Nijkamp FP
    Agents Actions; 1986 Dec; 19(5-6):366-7. PubMed ID: 2881459
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of a ribosomal vaccine against pertussis.
    Field LH; Parker CD; Manclark CR; Berry LJ
    Infect Immun; 1979 May; 24(2):346-51. PubMed ID: 222684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetically modified pertussis toxin: a quantum leap?
    McIntyre PB; Edwards KM
    Lancet Infect Dis; 2018 Nov; 18(11):1169-1171. PubMed ID: 30266328
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of ifferent bactericidal systems on B. prtussis and B. parapertussis organisms.
    Pusztai Z; Csizér Z; Joó I
    Z Immunitatsforsch Allerg Klin Immunol; 1970; 141(1):1-13. PubMed ID: 4322354
    [No Abstract]   [Full Text] [Related]  

  • 33. [Mitogenic action of the liquid phase of a microbial suspension of Bordetella pertussis].
    Amelina IP; Pronin AV; Lapaeva IA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jul; (7):6-10. PubMed ID: 2890249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The amino acid utilization by phase 1 Bordetella pertussis in a chemically defined medium.
    Goldner M; Jakus CM; Rhodes HK; Wilson RJ
    J Gen Microbiol; 1966 Sep; 44(3):439-44. PubMed ID: 4291280
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on the protection test of pertussis vaccine. Immunization period and protectivity. 3. Influence of heat and formation on the vaccine preparation.
    Yoshioka M; Takatsu K; Kawahira M; Takahashi K
    Jpn J Microbiol; 1967 Dec; 11(4):311-21. PubMed ID: 4297909
    [No Abstract]   [Full Text] [Related]  

  • 36. Purified K-agglutinogen of Bordetella pertussis and its properties.
    Nakase Y; Kasuga T
    Jpn J Microbiol; 1971 May; 15(3):247-56. PubMed ID: 4330023
    [No Abstract]   [Full Text] [Related]  

  • 37. Large-scale production of pertussis vaccine by serial subculture technic.
    Csizér Z; Joó I
    Zentralbl Bakteriol Orig A; 1972 Jul; 221(1):59-64. PubMed ID: 4145107
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of the passive immunization on the sensitizing activity of Bordetella pertussis. I. Increase of sensitivity to repeated homologous antigen administrations].
    Sumarokov AA; Kulikova IuM
    Zh Mikrobiol Epidemiol Immunobiol; 1965 May; 42(5):33-8. PubMed ID: 4161435
    [No Abstract]   [Full Text] [Related]  

  • 39. Antigens of Bordetella pertussis. I. Activities of cell walls and protoplasm.
    MUNOZ J; RIBI E; LARSON CL
    J Immunol; 1959 Nov; 83():496-501. PubMed ID: 14425265
    [No Abstract]   [Full Text] [Related]  

  • 40. Adjuvant activity of synthetic cell-wall peptidoglycan subunits on monoazobenzenearsonate-N-acetyl-L-tyrosine and bacterial alpha-amylase in guinea pigs.
    Azuma I; Sugimura K; Yamamura Y; Kusumoto S; Tarumi Y
    Jpn J Microbiol; 1976 Feb; 20(1):63-6. PubMed ID: 1271589
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.